Navigation Links
Barbiturate


Barbiturates are drugs that acts as central nervous system (CNS) depressants, and by virtue of this they produce a wide spectrum of effects, from mild sedation to anesthesia. Some also are used as anticonvulsants.

Barbiturates are derivatives of barbituric acid.

Contents

Medical uses

Today barbiturates come are mainly used as anticonvulsants and for the induction of anesthesia.

These barbiturates are available in the U.S.:

  • Amobarbital (Sodium Amytal; hypnotic)
  • Aprobarbital (hypnotic)
  • Butabarbital (hypnotic)
  • Butalbital (Fiorinal; sedative)
  • Hexobarbital (Sombulex; hypnotic/anesthetic)
  • Mephobarbital (antianxiety)
  • Pentobarbital (Nembutal; hypnotic)
  • Phenobarbital (Luminal; hypnotic, sedative, anticonvulsant)
  • Secobarbital (Seconal; hypnotic)
  • Sodium thiopental
  • Talbutal (Lotusate; hypnotic)
  • Thiobarbital (anesthetic)

Sometimes two or more barbiturates are combined in a single tablet or capsule; perhaps the most well-known of these combinations is Tuinal, which consists of amobarbital and secobarbital in equal proportions.

Barbiturate abuse

Barbiturates were very popular in the first half of the 20th century. In moderate amounts, these drugs produce a state of intoxication that is remarkably similar to alcohol intoxication. Symptoms include slurred speech, loss of motor coordination, and impaired judgment. Depending on the dose, frequency, and duration of use, one can rapidly develop tolerance, physical dependence, and psychological dependence to barbiturates. With the development of tolerance, the margin of safety between the effective dose and the lethal dose becomes very narrow. That is, in order to obtain the same level of intoxication, the tolerant abuser may raise his or her dose to a level that may result in coma or death. Although many individuals have taken barbiturates therapeutically without harm, concern about the addiction potential (withdrawal symptoms can include tonic-clonic or grand mal seizures potentially leading to permanent disability or even death) of barbiturates and the ever-increasing number of fatalities associated with them led to the development of alternative medications, namely benzodiazepines. Today, less than 10 percent of all sedative/hypnotic prescriptions in the United States are for barbiturates.

Other non-therapeutical use

Barbiturates in high doses are used for physician-assisted suicide (PAS), and, in combination with a muscle relaxant, for euthanasia and for capital punishment by lethal injection.

References


'"/>


(Date:8/4/2015)... 2015  AMRI (NASDAQ: AMRI ) today reported financial and ... Highlights: , Second quarter contract revenue of ... , Adjusted contract margins of 26 % ... a $0.05 decrease in EPS from royalties in the current quarter ... "We are very pleased to present another strong financial ...
(Date:8/3/2015)... SAN JOSE, Calif. , Aug. 3, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that members ... investment community at the Pacific Crest Global Technology Leadership ... Mountain Time. The conference will be held at the ... The presentation may include forward-looking information. ...
(Date:7/31/2015)... 31. juli 2015 Den 10. internationale konference ... BGI fra den 22. - 25. oktober i ... sin 10-års fødselsdag i år. Siden starten i 2006 ... møder på ,omik,-feltet, og er en af de mest ... ICG-10 fokuserer på nylige gennembrud og fremskridt inden for ...
Breaking Biology News(10 mins):AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2
... 2008Once believed to be important only for bone health, ... function in maintaining the immune system throughout life. The ... are clearly documented in a report in the December ... , a peer-reviewed journal published by Mary Ann Liebert, ...
... astronomy Apparao Rao has been named a Fellow of ... peers for outstanding contributions to physics. Fellowship is limited ... of the membership. Rao was recognized for developing ... properties of carbon nanotubes through Raman spectroscopy, a technique ...
... FASEB Journal shows that the equivalent of one dose ... may be enough to affect fetal heart development and then ... In addition, the researchers also found that this relatively minimal ... males, when compared to those who were not exposed to ...
Cached Biology News:Vitamin D deficiency in infants and nursing mothers carries long-term disease risks 2A low dose of caffeine when pregnant may damage the heart of offspring for a lifetime 2
Other biology definitionOther Tags